Magdalena Mazur

Magdalena Mazur is a seasoned professional with extensive experience in regulatory affairs, project management, and research within the biomedical field. Currently serving as a Regulatory Affairs Specialist at Worldwide Clinical Trials since March 2023 and as a Board Member for PesaChoice Group since October 2022, Magdalena has previously held roles at IQVIA, Nordic Biomed Innovations AB, and Karolinska Institutet, among others. Notably, Magdalena conducted significant research during a postdoctoral fellowship at AstraZeneca and completed a PhD in Medical Sciences at Lund University, with a focus on pancreatic endocrine cell differentiation. Expertise includes compliance with regulatory standards, project coordination, and board governance, complemented by academic achievements and hands-on laboratory expertise.